Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

SELL
$434.7 - $599.3 $198,223 - $273,280
-456 Reduced 45.69%
542 $291,000
Q2 2023

Aug 09, 2023

BUY
$350.74 - $468.98 $101,013 - $135,066
288 Added 40.56%
998 $468,000
Q1 2023

May 10, 2023

SELL
$310.63 - $364.82 $65,853 - $77,341
-212 Reduced 22.99%
710 $243,000
Q4 2022

Feb 13, 2023

BUY
$321.55 - $374.67 $91,963 - $107,155
286 Added 44.97%
922 $337,000
Q3 2022

Nov 10, 2022

BUY
$296.48 - $337.87 $81,828 - $93,252
276 Added 76.67%
636 $206,000
Q2 2022

Aug 08, 2022

BUY
$278.73 - $327.27 $19,232 - $22,581
69 Added 23.71%
360 $117,000
Q1 2022

May 11, 2022

SELL
$234.69 - $291.66 $145,507 - $180,829
-620 Reduced 68.06%
291 $83,000
Q4 2021

Feb 11, 2022

BUY
$224.85 - $279.04 $11,017 - $13,672
49 Added 5.68%
911 $252,000
Q3 2021

Nov 12, 2021

SELL
$221.6 - $272.71 $95,066 - $116,992
-429 Reduced 33.23%
862 $199,000
Q2 2021

Aug 10, 2021

BUY
$180.55 - $233.54 $61,387 - $79,403
340 Added 35.75%
1,291 $296,000
Q1 2021

May 14, 2021

SELL
$164.32 - $212.72 $123,240 - $159,540
-750 Reduced 44.09%
951 $178,000
Q4 2020

Feb 12, 2021

SELL
$130.46 - $172.63 $295,230 - $390,661
-2,263 Reduced 57.09%
1,701 $287,000
Q3 2020

Oct 30, 2020

BUY
$146.22 - $169.13 $232,928 - $269,424
1,593 Added 67.19%
3,964 $587,000
Q2 2020

Aug 13, 2020

BUY
$136.42 - $164.18 $323,451 - $389,270
2,371 New
2,371 $389,000
Q1 2019

May 10, 2019

SELL
$111.31 - $131.02 $1.04 Million - $1.22 Million
-9,328 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$105.9 - $118.64 $987,835 - $1.11 Million
9,328 New
9,328 $1.08 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Rock Creek Group, LP Portfolio

Follow Rock Creek Group, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rock Creek Group, LP, based on Form 13F filings with the SEC.

News

Stay updated on Rock Creek Group, LP with notifications on news.